Your browser doesn't support javascript.
loading
A Tunable Tumor Microenvironment through Recombinant Bacterial Collagen-Hyaluronic Acid Hydrogels.
Nemec, Stephanie; Ganda, Sylvia; Al Taief, Karrar; Kopecky, Chantal; Kuchel, Rhiannon; Lebhar, Hélène; Marquis, Christopher P; Thordarson, Pall; Kilian, Kristopher A.
Afiliación
  • Nemec S; School of Materials Science & Engineering, University of New South Wales, Sydney, Australia 2052.
  • Ganda S; Australian Centre for NanoMedicine, University of New South Wales, Sydney, Australia 2052.
  • Al Taief K; School of Chemistry, University of New South Wales, Sydney, Australia 2052.
  • Kopecky C; Australian Centre for NanoMedicine, University of New South Wales, Sydney, Australia 2052.
  • Kuchel R; School of Chemistry, University of New South Wales, Sydney, Australia 2052.
  • Lebhar H; Australian Centre for NanoMedicine, University of New South Wales, Sydney, Australia 2052.
  • Marquis CP; UNSW RNA Institute, University of New South Wales, Sydney, Australia 2052.
  • Thordarson P; School of Chemistry, University of New South Wales, Sydney, Australia 2052.
  • Kilian KA; Australian Centre for NanoMedicine, University of New South Wales, Sydney, Australia 2052.
ACS Appl Bio Mater ; 2022 Jun 07.
Article en En | MEDLINE | ID: mdl-35670558
ABSTRACT
Laboratory models of the tumor microenvironment require control of mechanical and biochemical properties to ensure accurate mimicry of patient disease. In contrast to pure natural or synthetic materials, hybrid approaches that pair recombinant protein fragments with synthetic scaffolding show many advantages. Here we demonstrate production of a recombinant bacterial collagen-like protein (CLP) for thiol-ene pairing to norbornene functionalized hyaluronic acid (NorHA). The resultant hydrogel material shows an adjustable modulus with evidence for strain-stiffening behavior that resembles natural tumor matrices. Cysteine terminated peptide binding motifs are incorporated to adjust the cell-adhesion points. The modular hybrid gel shows good biocompatibility and was demonstrated to control cell adhesion, proliferation, and the invasive properties of MCF7 and MD-MBA-231 breast adenocarcinoma cells. The ease in which multiple structural and bioactive components can be integrated provides a robust framework to form models of the tumor microenvironment for fundamental studies and drug development.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: ACS Appl Bio Mater Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: ACS Appl Bio Mater Año: 2022 Tipo del documento: Article